changsheng biotech, defective rabies vaccine, defective vaccines, rabies vaccine

Defective Rabies Vaccine by China’s Changsheng Biotech Sold Abroad

The China State Council has been investigating the defective rabies vaccine manufactured by Jilin-based Changsheng Biotechnology — one of China’s largest vaccine makers — after the China Food and Drug Administration ordered the company to halt production on July 15, 2018. The Council confirmed that some of the vaccine had been sold abroad and that ...

Nspirement Staff